Pfizer ups projection for COVID vaccine sales to $33.5 billion in 2021

Vials of the Pfizer-BioNTech COVID-19 vaccine are prepared for packaging at the company’s facility in Puurs, Belgium, March 2021. (Pfizer via AP)
Vials of the Pfizer-BioNTech COVID-19 vaccine are prepared for packaging at the company’s facility in Puurs, Belgium, March 2021. (Pfizer via AP)

NEW YORK — Pfizer sharply increases its 2021 projection for revenues tied to its COVID-19 vaccine, forecasting the delivery of 500 million more doses compared with earlier expectations.

The US drugmaker, who has partnered with Germany’s BioNTech on the vaccine, estimates delivering 2.1 billion doses, generating $33.5 billion in sales. The company’s May forecast was for $26 billion in sales.

Pfizer also lifts its full-year profit outlook.

Most Popular
If you’d like to comment, join
The Times of Israel Community.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.